कृपया अन्य खोज का प्रयास करें
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase II clinical trial to treat congenital, idiopathic, or cyclic neutropenia. The company is also developing X4P-003, a CXCR4 antagonist for the treatment of CXCR4 dependent disorders and primary immunodeficiencies; and X4P-002, a CXCR4 antagonist for the treatment of blood-brain barrier diseases. It has a license agreement with Abbisko Therapeutics Co Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company is headquartered in Boston, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Michael Stephen Wyzga | 66 | 2018 | Independent Chairman of the Board |
Rene Russo | 46 | 2019 | Director |
Paula Ragan | 53 | 2014 | CEO, President & Director |
Francoise de Craecker | 61 | 2021 | Independent Director |
Keith T. Flaherty | 52 | 2016 | Founder & Member of Corporate Advisory Board |
David W. J. McGirr | 69 | 2017 | Independent Director |
R. Keith Woods | 55 | 2023 | Independent Director |
Alison F. Lawton | 63 | 2016 | Independent Director |
Michael J. Vasconcelles | 61 | 2016 | Member of Corporate Advisory Board |
Gary J. Bridger | 61 | 2019 | Independent Director |
William E. Aliski | 78 | 2019 | Independent Director |
Murray W. Stewart | 62 | 2019 | Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है